David Natan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Parkland, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David Natan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David Natan

Form 4 holding Director

FiEE, Inc.

Security class
Common Stock
Shares / value
248,792
Estimated value
$1,754,331
Report date
05 May 2026
Price
$7.05
Ownership
Direct
Form 4 holding Director

OPGEN INC

Security class
Common Stock
Shares / value
100,000
Estimated value
$85,000
Report date
11 Apr 2024
Price
$0.8500
Ownership
Direct
Form 4 holding Chief Financial Officer

Crypto Co

Security class
Common Stock
Shares / value
55,000,000
Estimated value
Report date
12 Mar 2025
Price
Ownership
Direct
Form 4 holding Director

Cyclacel Pharmaceuticals, Inc.

Security class
Non-Qualified Stock Option (Right to Buy)
Shares / value
700,000
Estimated value
Report date
26 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Quantum Cyber N.V.

Security class
Stock Option (Right to Buy)
Shares / value
190,840
Estimated value
Report date
31 Jul 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

TITAN PHARMACEUTICALS INC

Security class
Option to Purchase Common Stock
Shares / value
100,000
Estimated value
Report date
29 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David Natan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .